Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis

Affiliations

• ¹ Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, 19692-00202 Nairobi, Kenya. Electronic address: chakaya.jm@gmail.com.
• ² The Children's Hospital at Westmead, University of Sydney, Sydney, NSW, Australia.
• ³ Burnet Institute, Melbourne, Vic, Australia.
• ⁴ Université Marien Ngouabi, Fondation Congolaise pour la Recherche Médicale, Brazzaville, Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
• ⁵ National Institute for Medical Research, Dar-Es-Salaam, Tanzania; Muhimbili University of Health and Allied Sciences, Dar-Es-Salaam, Tanzania; Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania; Liverpool School of Tropical Medicine, Liverpool, UK.
• ⁶ Zambia Public Health Institute, Ministry of Health, Lusaka, Zambia.
• ⁷ Jamia Hamdard Institute of Molecular Medicine, New Delhi, India.
• ⁸ Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA; TB Proof, Cape Town, South Africa.
• ⁹ Department of Infection, Division of Infection and Immunity, University College London, London, UK; National Institute for Health Research Biomedical Research Centre, University College London Hospitals National Health Service Foundation Trust, London, UK.